Catalyst Wire Dossier Catalyst Wire Dossier

Contrave (naltrexone/bupropion)

naltrexone/bupropion · Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Contrave (naltrexone/bupropion), covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) [Phase 4]

See pricing